XML 76 R65.htm IDEA: XBRL DOCUMENT v2.4.0.6
Common and Preferred Stock (Restricted Stock, Performance Share Awards and Options Activity) (Details) (USD $)
In Millions, except Share data, unless otherwise specified
12 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Restricted Stock Awards [Member]
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting period (in years) 3 years    
Activity [Roll Forward]      
Nonvested balance at beginning of year (in shares) 1,154,590    
Granted (in shares) 452,488    
Vested (in shares) (521,882)    
Forfeited (in shares) (52,908)    
Nonvested balance at end of year (in shares) 1,032,288 1,154,590  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]      
Nonvested balance at beginning of year, weighted-average grant date fair value (in dollars per share) $ 50.40    
Granted, weighted-average grant date fair value (in dollars per share) $ 54.77 $ 46.72 $ 51.50
Vested, weighted-average grant date fair value (in dollars per share) $ 53.22    
Forfeited, weighted-average grant date fair value (in dollars per share) $ 51.34    
Nonvested balance at end of year, weighted-average grant date fair value (in dollars per share) $ 50.84 $ 50.40  
Performance Share Awards [Member]
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting period (in years) 3 years    
Activity [Roll Forward]      
Nonvested balance at beginning of year (in shares) 1,318,398    
Granted (in shares) 566,386    
Vested (in shares) (448,416)    
Forfeited (in shares) (85,294)    
Nonvested balance at end of year (in shares) 1,351,074 1,318,398  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]      
Nonvested balance at beginning of year, weighted-average grant date fair value (in dollars per share) $ 45.96    
Granted, weighted-average grant date fair value (in dollars per share) $ 50.13 $ 42.95 $ 42.66
Vested, weighted-average grant date fair value (in dollars per share) $ 58.42    
Forfeited, weighted-average grant date fair value (in dollars per share) $ 43.34    
Nonvested balance at end of year, weighted-average grant date fair value (in dollars per share) $ 43.72 $ 45.96  
Restricted Stock and Performance Share Awards [Member]
     
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]      
Total fair value of awards vested $ 53 $ 47 $ 46
Options [Member]
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting period (in years) 3 years    
Maximum term (in years) 10 years    
Option activity [Roll Forward]      
Shares underlying options - Balance at beginning of year (in shares) 5,036,652    
Shares underlying options - Granted (in shares) 536,302    
Shares underlying options - Exercised (in shares) (1,065,939)    
Shares underlying options - Forfeited (in shares) (102,451)    
Shares underlying options - Expired (in shares) (18,699)    
Shares underlying options - Balance at end of year (in shares) 4,385,865 5,036,652  
Shares underlying options - Exercisable (in shares) 3,348,329    
Additional disclosures pertaining to options [Abstract]      
Balance at beginning of year, weighted average exercise price (in dollars per share) $ 38.69    
Granted, weighted average exercise price (in dollars per share) $ 54.59    
Exercised, weighted average exercise price (in dollars per share) $ 29.14    
Forfeited, weighted average exercise price (in dollars per share) $ 50.49    
Expired, weighted average exercise price (in dollars per share) $ 47.42    
Balance at end of year, weighted average exercise price (in dollars per share) $ 42.64 $ 38.69  
Exercisable at end of year, weighted average exercise price (in dollars per share) $ 40.15    
Balance at end of year, weighted average remaining contractual term (years) 4.7    
Balance at end of year, aggregate intrinsic value 81    
Exercisable at end of year, weighted average remaining contractual term (years) 3.6    
Exercisable at end of year, aggregate intrinsic value 71    
Granted, weighted average grant date fair value (in dollars per share) $ 7.78 $ 6.22 $ 6.79
Total intrinsic value of stock options exercised 29 32 9
Cash received from option exercises 31 41 10
Tax benefit realized from options exercised $ 11 $ 12 $ 3